ILLUMINA INC (ILMN) Stock Price & Overview
NASDAQ:ILMN • US4523271090
Current stock price
The current stock price of ILMN is 118.94 USD. Today ILMN is up by 2.92%. In the past month the price increased by 3.93%. In the past year, price increased by 38.95%.
ILMN Key Statistics
- Market Cap
- 18.186B
- P/E
- 24.52
- Fwd P/E
- 22.73
- EPS (TTM)
- 4.85
- Dividend Yield
- N/A
ILMN Stock Performance
ILMN Stock Chart
ILMN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ILMN. When comparing the yearly performance of all stocks, ILMN is one of the better performing stocks in the market, outperforming 77.26% of all stocks.
ILMN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ILMN. ILMN scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
ILMN Earnings
On February 5, 2026 ILMN reported an EPS of 1.35 and a revenue of 1.16B. The company beat EPS expectations (7.62% surprise) and beat revenue expectations (2.75% surprise).
ILMN Forecast & Estimates
28 analysts have analysed ILMN and the average price target is 138.42 USD. This implies a price increase of 16.38% is expected in the next year compared to the current price of 118.94.
For the next year, analysts expect an EPS growth of 7.88% and a revenue growth 5.74% for ILMN
ILMN Groups
Sector & Classification
ILMN Financial Highlights
Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 4.85. The EPS increased by 97.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.57% | ||
| ROA | 12.79% | ||
| ROE | 31.22% | ||
| Debt/Equity | 0.55 |
ILMN Ownership
ILMN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 18.72 | 172.504B | ||
| DHR | DANAHER CORP | 22.06 | 132.461B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 126.64 | 41.658B | ||
| A | AGILENT TECHNOLOGIES INC | 16.67 | 31.524B | ||
| WAT | WATERS CORP | 19.72 | 28.113B | ||
| IQV | IQVIA HOLDINGS INC | 12.85 | 27.652B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.03 | 23.862B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.06 | 16.958B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.84 | 12.783B | ||
| RVTY | REVVITY INC | 15.52 | 9.567B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.935B | ||
| TECH | BIO-TECHNE CORP | 22.85 | 7.955B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ILMN
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
IPO: 2000-06-28
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 9000
Phone: 13026587581
ILLUMINA INC / ILMN FAQ
Can you describe the business of ILLUMINA INC?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Can you provide the latest stock price for ILLUMINA INC?
The current stock price of ILMN is 118.94 USD. The price increased by 2.92% in the last trading session.
Does ILLUMINA INC pay dividends?
ILMN does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILMN stock?
ILMN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about ILLUMINA INC (ILMN) stock?
28 analysts have analysed ILMN and the average price target is 138.42 USD. This implies a price increase of 16.38% is expected in the next year compared to the current price of 118.94.
What sector and industry does ILLUMINA INC belong to?
ILLUMINA INC (ILMN) operates in the Health Care sector and the Life Sciences Tools & Services industry.